Vivus (VVUS)

pos +0.00
Today's Range: 1.00 - 1.10 | VVUS Avg Daily Volume: 1,301,400
Last Update: 02/05/16 - 3:59 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $0.99
52 Week Range: $0.92 - $3.14
Oustanding Shares: 104,036,005
Market Cap: 102,995,645
6-Month Chart
TheStreet Ratings Grade for VVUS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 0 1 1 1
Hold 2 2 2 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.75 2.60 2.60 2.60
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -0.96
Price Earnings Comparisons:
VVUS Sector Avg. S&P 500
-0.96 0.00 30.32
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-37.04% -60.47% -92.13%
Revenue 40.80 0.00 0.00
Net Income 0.00 0.76 0.00
EPS 0.00 0.45 0.00
Earnings for VVUS:
Revenue 0.11B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $-0.13 $n.a. $-0.62 $-0.40
Number of Analysts 2 0 2 2
High Estimate $-0.11 $n.a. $-0.60 $-0.32
Low Estimate $-0.15 $n.a. $-0.63 $-0.48
Prior Year $-0.25 $-0.15 $-0.77 $-0.62
Growth Rate (Year over Year) 48.00% n.a.% 20.13% 34.96%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
These companies should feast as more obese Americans turn to exercise and healthy foods.

Looking at What Didn't Work Real Money Pro($)

Time to examine a couple that didn't pan out.
Oct 16, 2013 | 8:52 AM EDT
VVUS was downgraded to Neutral from Overweight, according to Piper Jaffray. Headwind from increased competition and lack of partnership...

2 Ways to Play Vivus Real Money Pro($)

The short-term picture has changed.

Viva La Vivus? Real Money Pro($)

This looks ready to make a move higher.
Some of the market's favorite stocks have entered a danger zone.
Sep 04, 2013 | 7:33 AM EDT
VVUS was downgraded to Sell, Lazard Capital Markets said. $8 price target. Qsymia has had a slow launch and the company's patents could...
Aug 07, 2013 | 7:44 AM EDT
VVUS estimates lowered through 2013, Jefferies said. $5 price target. Weak 2Q but signs of acceleration in 3Q. Underperform rating.&nbs...
Jul 23, 2013 | 8:15 AM EDT
VVUS was removed from the US1 list, according to Bank of America/Merrill Lynch. An inflection in Qsymia prescriptions could take time. ...
Jul 15, 2013 | 8:25 AM EDT
VVUS was downgraded from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $15 price target. 

Columnist Conversations

Flat as a pancake. Thus far, Jim "El Capitan" Cramer doesnt yet get his wish.
We had expected a recovery in energy prices and better things from the stocks for some time. So far, we have b...
Industrials have seen their revenues and earnings outlook slow in the past year due to a slowing China and a b...
Get your cues from market legends like Jesse Livermore...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.